新西梅顿衍生物的肝保护性质,具有修改结构的分子
A B Vyshtakalyuk1, A A Parfenov2, V E Semenov2
1Arbuzov Institute of Organic and Physical Chemistry - Separated Division of Kazan Scientific Center, Russian Academy of Sciences, Kazan, Russia. alex.vysh@mail.ru.
Bulletin of experimental biology and medicine
|April 28, 2025
概括
新的Xymedon修改 (2) 和 (3) 在保护肝细胞免受损伤方面表现有前途. 化合物 (2) 显示出显著的细胞保护作用,并减少了大鼠的肝损伤,使其成为进一步研究的更有前途的候选人.
科学领域:
- 药理学 药理学是指药理学的学科.
- 肝病学 肝病学是一种肝病学.
- 药物开发 药物开发
背景情况:
- 克西梅顿是一款俄罗斯的再生刺激器.
- 合成了Xymedon的新化学修饰,以探索增强的治疗特性.
- 肝护剂对于治疗肝病至关重要.
研究的目的:
- 评估新型Xymedon衍生物 (化合物2和3) 对人类肝脏细胞系的细胞毒性和细胞保护作用.
- 评估这些化合物的体内肝保护活性,使用碳四化物 (CCl4) 诱导的小鼠肝损伤模型.
- 为了确定未来药物开发中最有前途的Xymedon修饰.
主要方法:
- 细胞毒性测定在肝,HepG2和WI-38人类细胞系上进行.
- 评估了对d-galactosamine诱导的细胞损伤的细胞保护作用.
- 在Wistar小鼠中评估了CCl4诱导的肝损伤的体内肝保护活性,并监测了损伤的形态征兆.
主要成果:
- 化合物 (2) 和 (3) 已证明具有细胞保护性,在有毒条件下增强细胞活力.
- 这两种化合物都减少了CCl4.4引起的肝损伤的形态迹象.
- 与化合物 (2) 相比,化合物 (3) 的细胞毒性更高.
结论:
- 化合物 (2),是一种新型Xymedon修饰,显示出显著的肝保护潜力,细胞毒性较低.
- 化合物 (2) 是一个比化合物 (3) 更有前途的候选人,用于进一步研究和开发作为肝脏保护剂.
- 这些发现支持对修改后的Xymedon衍生物用于治疗肝损伤的探索.
相关概念视频
Prodrugs
2.3K
Prodrugs are a class of pharmaceutical compounds that undergo a biotransformation process within the body to be converted into a pharmacologically active drug. Prodrugs are designed to improve the therapeutic properties of the parent drug, such as enhancing bioavailability, increasing stability, or reducing toxicity. The concept of prodrugs revolves around modifying the chemical structure of the original drug to make it more effective or convenient for administration.
Prodrugs help overcome...
Prodrugs help overcome...
2.3K
Drug Biotransformation: Overview
2.2K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
2.2K
Drug Metabolism: Phase II Reactions
3.4K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.4K
Opioid Analgesics: Synthetic and Semisynthetic Opioids
169
Synthetic and semisynthetic opioids are pivotal in pain management and tackling opioid addiction. Semisynthetic opioids, including morphinans (morphine derivatives), oxycodone, oxymorphone, hydrocodone, and hydromorphone, have improved pharmacokinetic profiles compared to morphine. Additionally, heroin and 6-MAM (6-Monoacetylmorphine) show better CNS penetration than morphine due to heightened lipid solubility. Hydromorphone, a potent opioid, undergoes hepatic metabolism to form the active...
169
Antidotes
593
Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
593


